Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 11 studies | 33% ± 11% | |
endothelial cell | 9 studies | 28% ± 10% | |
fibroblast | 8 studies | 25% ± 9% | |
epithelial cell of proximal tubule | 7 studies | 34% ± 10% | |
epithelial cell | 6 studies | 38% ± 24% | |
kidney loop of Henle epithelial cell | 5 studies | 28% ± 11% | |
natural killer cell | 5 studies | 24% ± 6% | |
connective tissue cell | 5 studies | 21% ± 5% | |
endothelial cell of lymphatic vessel | 4 studies | 22% ± 4% | |
astrocyte | 4 studies | 25% ± 8% | |
gamma-delta T cell | 4 studies | 31% ± 14% | |
hepatocyte | 4 studies | 35% ± 26% | |
pancreatic A cell | 3 studies | 29% ± 11% | |
type B pancreatic cell | 3 studies | 32% ± 9% | |
conventional dendritic cell | 3 studies | 22% ± 4% | |
mature NK T cell | 3 studies | 17% ± 1% | |
renal alpha-intercalated cell | 3 studies | 29% ± 8% | |
erythroblast | 3 studies | 40% ± 12% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 18% ± 3% | |
macrophage | 3 studies | 18% ± 3% | |
endothelial cell of vascular tree | 3 studies | 17% ± 1% | |
erythrocyte | 3 studies | 33% ± 14% | |
plasmacytoid dendritic cell | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 4698.41 | 226 / 226 | 100% | 57.17 | 406 / 406 |
kidney | 100% | 4527.25 | 89 / 89 | 100% | 21.79 | 900 / 901 |
brain | 100% | 1681.29 | 2635 / 2642 | 100% | 27.06 | 705 / 705 |
prostate | 100% | 2007.38 | 244 / 245 | 100% | 38.58 | 502 / 502 |
thymus | 100% | 1642.18 | 652 / 653 | 100% | 17.03 | 603 / 605 |
adrenal gland | 100% | 5664.21 | 258 / 258 | 99% | 27.87 | 228 / 230 |
ovary | 100% | 2714.92 | 180 / 180 | 97% | 11.71 | 418 / 430 |
pancreas | 100% | 2741.23 | 328 / 328 | 97% | 14.26 | 172 / 178 |
breast | 100% | 2507.50 | 459 / 459 | 95% | 22.05 | 1067 / 1118 |
skin | 99% | 1740.22 | 1795 / 1809 | 96% | 16.18 | 454 / 472 |
lung | 98% | 1319.53 | 568 / 578 | 92% | 11.06 | 1064 / 1155 |
esophagus | 99% | 1423.42 | 1436 / 1445 | 91% | 8.23 | 166 / 183 |
stomach | 100% | 3636.51 | 359 / 359 | 89% | 9.33 | 255 / 286 |
intestine | 100% | 2127.89 | 966 / 966 | 87% | 10.08 | 460 / 527 |
bladder | 100% | 1642.86 | 21 / 21 | 87% | 10.24 | 438 / 504 |
uterus | 100% | 2013.47 | 170 / 170 | 78% | 12.79 | 359 / 459 |
adipose | 100% | 2331.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.47 | 29 / 29 |
muscle | 100% | 4794.40 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1619.56 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.84 | 1 / 1 |
blood vessel | 100% | 1398.47 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3705.57 | 849 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 17.20 | 78 / 80 |
tonsil | 0% | 0 | 0 / 0 | 82% | 9.19 | 37 / 45 |
peripheral blood | 40% | 546.02 | 374 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006635 | Biological process | fatty acid beta-oxidation |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005829 | Cellular component | cytosol |
GO_0005777 | Cellular component | peroxisome |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0000062 | Molecular function | fatty-acyl-CoA binding |
GO_0004165 | Molecular function | delta(3)-delta(2)-enoyl-CoA isomerase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ECI2 |
Protein name | Enoyl-CoA delta isomerase 2 Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1) Enoyl-CoA delta isomerase 2 (Testicular secretory protein Li 33) |
Synonyms | DRS1 PECI HCA88 |
Description | FUNCTION: Able to isomerize both 3-cis and 3-trans double bonds into the 2-trans form in a range of enoyl-CoA species. Has a preference for 3-trans substrates. . |
Accessions | ENST00000361538.6 A0A0C4DGA2 ENST00000380120.6 O75521 F1LLU7 F8W6J1 ENST00000380125.6 ENST00000496241.6 ENST00000380118.8 [O75521-1] ENST00000465828.5 ENST00000478266.6 F8WAW4 C9JB63 ENST00000495548.1 |